New study tracks brain and body side effects of prostate cancer drugs

NCT ID NCT07181122

Recruiting now Knowledge-focused Sponsor: Ankara Etlik City Hospital Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 12, 2026 · Updated 24 times

Summary

This study follows 102 men with advanced prostate cancer to see how their thinking, energy, mood, and sleep change during treatment with hormone therapy plus newer targeted drugs. Participants fill out questionnaires at the start, 3 months, and 6 months. The goal is to understand real-world side effects and help doctors better support patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Etlik City Hospital Medical Oncology Department
RECRUITING

Ankara, Yenimahalle, 06270, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Gazi University Medical Oncology Department
RECRUITING

Ankara, Çankaya, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)